| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |